GERON CORP (GERN) Stock Price, Quote, News and Overview
NASDAQ:GERN - Nasdaq - US3741631036 - Common Stock
GERN Quote and Key Statistics
GERON CORP
NASDAQ:GERN (1/22/2025, 3:59:52 PM)
After market: 2.99 0 (-0.17%)2.995
+0.04 (+1.18%)
GERN Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.22% | ||
| ROE | -68.83% | ||
| Debt/Equity | 0.04 |
GERN Performance and Technical Analysis
GERN Ownership and Analysts
GERN Latest News and Analysis
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About GERN
Company Profile
Geron Corp. operates as a biotechnology company. The company is headquartered in Foster City, California and currently employs 141 full-time employees. The firm is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. The company is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. The company is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Company Info
GERON CORP
919 East Hillsdale Boulevard, Suite 250
Foster City CALIFORNIA 94404 US
CEO: John A. Scarlett
Employees: 141
Company Website: https://www.geron.com/
Investor Relations: https://ir.geron.com/
Phone: 16504737700
GERN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.74 | 298.96B | ||
| AMGN | AMGEN INC | 14.24 | 147.08B | ||
| GILD | GILEAD SCIENCES INC | 21 | 115.92B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 839.02 | 110.20B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.96 | 74.68B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.25B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.37B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.70B | ||
| NTRA | NATERA INC | N/A | 22.69B | ||
| BIIB | BIOGEN INC | 8.74 | 20.80B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.35B |